SWGMS Genomics Laboratory Information Management System (GLIMS)
Estimated value
£5.5m
Awarded value
—
Suppliers
0
Lots
1
Published
08 May 2026
Description
Bristol and Weston Purchasing Consortium ("BWPC") on behalf of the Authority North Bristol NHS Trust ("NBT") are submitting a Tender Notice for the replacement of the Genomics Laboratory Information Management Systems ("GLIMS") at NBT and Royal Devon University Healthcare NHS Foundation Trust ("RDUH"). Both Trusts are responsible for the provision of genomic testing on behalf of the South-West Genomic Medicine Service ("SWGMS"). The current LIMS platforms at both NBT and RDUH are 15 years old and do not support the level of integration, scalability, or interoperability required to meet the SWGMS future needs. The aim is to deliver a future-ready digital platform with regional integration capability, aligned with the NHS England (NHSE) Genomic Medicine Service strategy, supporting the delivery of interoperable, scalable, and efficient genomic services and the ambitions for genomic medicine outlined in the 10-year plan. NBT are therefore seeking a strategic GLIMS partner capable of supporting an integrated, multi-site, high-throughput genomic service. The scope of the procurement includes the provision, implementation, configuration, and ongoing support of a GLIMS to support SWGMS laboratory services across both in-scope sites. This includes core laboratory workflow management, sample tracking, test ordering, results management, reporting, audit, quality management support, and administration. The scope also includes system hosting (where applicable), system integration, data migration from legacy systems, training, change management support, and business-as-usual support services.
Scope
- Reference
- WS3086583700
- Total value
- £5,500,000 excluding VAT£6,600,000 including VATAbove the relevant threshold
- Commercial tool
- Standalone contract
- Contract dates
- 31 May 2027 to 01 Jun 2035Possible extension to 01 Jun 2037
The anticipated contract length is planned for 8 years with two optional extensions (8+1+1).
- Main category
- services
- CPV classifications
- 480000007200000085111800
- Contract locations
- UK, United Kingdom
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Quality | The Contracting Authority reserves the right to refine and finalise the award criteria, including specific quality and price criteria, weightings and scoring methodology, during the procurement process following dialogue with shortlisted suppliers. Refinement may occur following dialogue stages and prior to the issue of Invitations for Bid submissions. | quality | 60.00% |
| Price | The Contracting Authority reserves the right to refine and finalise the award criteria, including specific quality and price criteria, weightings and scoring methodology, during the procurement process following dialogue with shortlisted suppliers. Refinement may occur following dialogue stages and prior to the issue of Invitations for Bid submissions. | price | 30.00% |
| Social Value | — | quality | 10.00% |
Participation
Conditions suppliers must meet to bid.
The legal and financial capacity conditions for this procurement, will be provided within the Procurement Specific Questionnaire ("PSQ") Suppliers' economic and financial standing will be assessed as a condition of participation, using a risk based and proportionate approach aligned with Cabinet Office guidance for Gold classified contracts.
The PSQ will ask Suppliers to provide up to 3 contract references, and we will assess the extent to which each supplier's previous delivery experience demonstrates capability across the following aspects: Relevance - Delivery of GLIMS or LIMS solutions within genomic or other regulated laboratory environments. Scale - Experience delivering solutions of comparable scale, including throughput volumes, users, and/or number of sites. Complexity - Experience involving delivery challenges such as data migration, system integrations, and validation in regulated clinical settings. Delivery Responsibility - The degree to which the supplier held primary (prime) responsibility for delivery, as opposed to a limited or supporting role.
The Authority intends to use the PSQ to limit the number of suppliers invited to participate in the next stage of the procurement process. Subject to the outcome of this assessment, the Authority intends to invite up to 4 suppliers to progress to the next stage (ITPD). The Authority will assess the extent to which each supplier's previous delivery experience demonstrates capability across the following aspects: Relevance - Delivery of GLIMS or LIMS solutions within genomic or other regulated laboratory environments. Scale - Experience delivering solutions of comparable scale, including throughput volumes, users, and/or number of sites. Complexity - Experience involving delivery challenges such as data migration, system integrations, and validation in regulated clinical settings. Delivery Responsibility - The degree to which the supplier held primary (prime) responsibility for delivery, as opposed to a limited or supporting role.
Submission & procedure
- Submission address
- The PSQ will be issued from our e-tendering portal, SAP Ariba. Responses must be returned in the same way. All details will be issued with the PSQ. https://supplier.ariba.com/
- Electronic submission
- Yes
- Procedure
- Competitive flexible procedure